Date: Aug 4, 2026 07:00 PM ET

This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on residents living in a long-term care setting. Participants will review the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer’s disease. The program will also provide an overview of the Centers for Medicare & Medicaid Services Regulations on Antipsychotics.

News Category
News Archive Date